mephobarbital has been researched along with Stunted Growth in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hanson, JW; Smith, DW | 1 |
| Hill, RM; Horning, MG; McCulley, LB; Morgan, NF; Verniaud, WM | 1 |
2 other study(ies) available for mephobarbital and Stunted Growth
| Article | Year |
|---|---|
The fetal hydantoin syndrome.
Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Adolescent; Child, Preschool; Developmental Disabilities; Epilepsy; Female; Fetus; Fingers; Growth Disorders; Humans; Hydantoins; Hypertelorism; Infant; Intellectual Disability; Male; Mephobarbital; Motor Skills; Mouth Abnormalities; Myoclonus; Nails, Malformed; Phenobarbital; Pregnancy; Pregnancy Complications; Primidone; Succinimides; Syndrome; Teratogens; Toes | 1975 |
Infants exposed in utero to antiepileptic drugs. A prospective study.
Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Amitriptyline; Amniotic Fluid; Anticonvulsants; Chromatography, Gas; Diazepam; Epilepsy; Ethosuximide; Female; Fetus; Growth Disorders; Humans; Hydantoins; Infant, Newborn; Mass Spectrometry; Mephobarbital; Meprobamate; Milk, Human; Phenobarbital; Phenytoin; Pregnancy; Pregnancy Complications; Primidone; Prochlorperazine; Prospective Studies; Substance Withdrawal Syndrome; Succinimides; Time Factors | 1974 |